WFAG
GILD icon

Wescott Financial Advisory Group’s Gilead Sciences GILD Stock Holding History

Wescott Financial Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518K Buy
3,714
+46
+1% +$6.44K 0.05% 125
2025
Q4 		$450K Buy
3,668
+122
+3% +$14.8K 0.04% 132
2025
Q3 		$394K Sell
3,546
-5
-0.1% -$568 0.04% 136
2025
Q2 		$394K Sell
3,551
-19
-0.5% -$2.02K 0.04% 131
2025
Q1 		$400K Buy
3,570
+17
+0.5% +$1.75K 0.04% 123
2024
Q4 		$328K Buy
3,553
+182
+5% +$16.4K 0.03% 134
2024
Q3 		$283K Buy
3,371
+6
+0.2% +$458 0.03% 151
2024
Q2 		$231K Buy
+3,365
New +$225K 0.03% 155

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wescott Financial Advisory Group's GILD Position: Q1 2026 in Review

Wescott Financial Advisory Group increased its Gilead Sciences (GILD) stake by 1.3% in Q1 2026, buying an estimated $6.44K and bringing the position to 3,714 shares worth $518K. The position accounts for 0.05% of the portfolio, ranked #125.

Wescott Financial Advisory Group first reported a position in GILD in Q2 2024 and has held it in 8 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Wescott Financial Advisory Group held 3,714 shares of Gilead Sciences worth $518K as of Q1 2026.
  • Wescott Financial Advisory Group bought 46 Gilead Sciences shares in Q1 2026, an estimated $6.44K.
  • Gilead Sciences made up 0.05% of Wescott Financial Advisory Group's portfolio in Q1 2026, its #125 holding.
  • Wescott Financial Advisory Group first reported a position in Gilead Sciences in Q2 2024 and has held it in 8 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wescott Financial Advisory Group's 13F filing for Q1 2026, filed 12 May 2026.